Clinical Trial Update: Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating autologous bone marrow-derived mononuclear cell transplantation for neurological sequelae following head injury has completed, repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Autologous bone marrow-derived mononuclear cell transplantation (bone marrow-derived mononuclear cells (autologous))

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Sequelae of Injuries of Head | Phase 1, Phase 2 | Status: COMPLETED